Christian Waage

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$231,062.02
Insider Sells Quantity
7
Insider Sells Sum
$184,997.38

Insider Activity of Christian Waage

According to the SEC Form 4 filings, Christian Waage, being in a position of

  1. EVP, Tech Ops and Admin at Gossamer Bio, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6430 shares for $7,430,
    over all time since 2019-02-12, has bought 17034 shares for $180,539, and sold 22642 shares for $155,067.

The largest purchase of all time was on 2019-05-15 and amounted to 2800 shares of Heron Therapeutics, Inc. for $50,523.

The largest sale of all time was on 2022-03-23 and amounted to 10722 shares of Gossamer Bio, Inc. for $95,587.

Biography of Christian Waage

No biography is available at this moment.

2024-03-27SaleGossamer Bio, Inc.
GOSS
EVP, Tech Ops and Admin
6,430
0.0028%
$1.16$7,430-26.66%
2022-07-15PurchaseGossamer Bio, Inc.
GOSS
EVP, Tech Ops and Admin
6,934
0.0049%
$7.21$49,994-79.92%
2022-03-23SaleGossamer Bio, Inc.
GOSS
EVP, Tech Ops and Admin
10,722
0.0143%
$8.91$95,587-4.09%
2021-12-21SaleHeron Therapeutics, Inc.
HRTX
director
300
0.0003%
$9.73$2,920-56.73%
2021-09-21SaleHeron Therapeutics, Inc.
HRTX
director
600
0.0006%
$12.31$7,384-54.08%
2021-06-21SaleHeron Therapeutics, Inc.
HRTX
director
600
0.0006%
$15.20$9,118-40.1%
2021-04-15SaleHeron Therapeutics, Inc.
HRTX
director
600
0.0006%
$17.51$10,508-38.97%
2021-03-23SaleGossamer Bio, Inc.
GOSS
EVP & General Counsel
5,490
0.0077%
$9.48$52,051+1.54%
2020-10-14PurchaseGossamer Bio, Inc.
GOSS
EVP & General Counsel
5,000
0.0075%
$9.53$47,636-1.07%
2019-09-27PurchaseGossamer Bio, Inc.
GOSS
EVP & General Counsel
2,000
0.0032%
$16.65$33,308-20.65%
2019-05-15PurchaseHeron Therapeutics, Inc.
HRTX
director
2,800
0.0035%
$18.04$50,523+1.43%
2019-02-12PurchaseGossamer Bio, Inc.
GOSS
EVP & General Counsel
3,100
0.0074%
$16.00$49,600+6.27%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.